Engineered t cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.

e15048Background: T-cell receptor (TCR) gene-engineered T cell therapy is a promising cancer treatment strategy. Its successful development for epithelial cancers may depend on the identification o...